These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Future perspectives for biological response modifiers: a viewpoint. Mihich E Semin Oncol; 1986 Jun; 13(2):234-54. PubMed ID: 2424090 [No Abstract] [Full Text] [Related]
3. [Definition of tumor-necrosis factor and its production mechanism]. Urushizaki I; Niitsu Y; Watanabe N Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100 [TBL] [Abstract][Full Text] [Related]
4. Effect of forphenicinol on the production of lipopolysaccharide-induced interferon and tumor necrosis factor and on the growth of Meth A fibrosarcoma in mice. Okura A; Nakadaira M; Naito K; Arakawa H; Ishizuka M; Takeuchi T; Umezawa H J Biol Response Mod; 1987 Feb; 6(1):28-34. PubMed ID: 2435854 [TBL] [Abstract][Full Text] [Related]
5. [A review on mechanism of anti-tumor action of BCG (author's transl)]. Tokunaga T Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202 [No Abstract] [Full Text] [Related]
7. Effect of BCG on cytostatic activity of peritoneal macrophages from normal and tumor-bearing rats. Chikama M; Saijo N; Irimajiri N; Niitani H Gan; 1979 Apr; 70(2):229-33. PubMed ID: 467886 [TBL] [Abstract][Full Text] [Related]
8. Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer. Shang Z; Li Y; Hsu I; Zhang M; Tian J; Wen S; Han R; Messing EM; Chang C; Niu Y; Yeh S Oncotarget; 2016 May; 7(19):27325-35. PubMed ID: 27092883 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Winkelhake JL; Stampfl S; Zimmerman RJ Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of BCG antitumor actions and genetic background of the host]. Tokunaga T Kekkaku; 1977 Oct; 52(10):527-8. PubMed ID: 599770 [No Abstract] [Full Text] [Related]
11. Activated macrophages and the antitumor action of BCG. Alexander P Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313 [No Abstract] [Full Text] [Related]
12. Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Matthews N Br J Cancer; 1981 Sep; 44(3):418-24. PubMed ID: 7284238 [TBL] [Abstract][Full Text] [Related]
14. Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems. Chun M; Hoffmann MK Cancer Res; 1987 Jan; 47(1):115-8. PubMed ID: 3791198 [TBL] [Abstract][Full Text] [Related]
16. [Cancer and BCG]. Rumi LS Acta Physiol Lat Am; 1981; 31(1):25-34. PubMed ID: 7187581 [TBL] [Abstract][Full Text] [Related]
17. BCG and cancer. Rapp HJ; Zbar B J Natl Cancer Inst; 1981 Nov; 67(5):991. PubMed ID: 6946254 [No Abstract] [Full Text] [Related]
18. Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines. Hanna MG; Peters LC; Hoover HC Prog Clin Biol Res; 1989; 310():51-65. PubMed ID: 2672023 [No Abstract] [Full Text] [Related]
19. [Effect of the joint use of BCG and antithymocyte serum on the growth of a syngeneic tumor in mice]. Babadzhanov AS; Slavina EG Biull Eksp Biol Med; 1983 Feb; 95(2):68-70. PubMed ID: 6600630 [TBL] [Abstract][Full Text] [Related]
20. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Balkwill FR; Lee A; Aldam G; Moodie E; Thomas JA; Tavernier J; Fiers W Cancer Res; 1986 Aug; 46(8):3990-3. PubMed ID: 2425938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]